WhiteOak Capital Mutual Fund · Equity · Sectoral / Thematic · Direct plan
WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth
₹17.441NAV on 30 Oct 2026Expense ratio 1.07%
29 Oct 2025NAV low 13.39 · high 17.97+19.3%
In plain words
Its worst fall from a peak in the last 3 years was -15.4%.
Past returns, not a promise of future returns or a recommendation.
Returns vs benchmark
| Period | Fund | Benchmark |
|---|---|---|
| 1 month | +0.9% | +1.9% |
| 3 months | +1.3% | -5.1% |
| 6 months | +18.0% | -3.2% |
| 1 year | +19.6% | -10.2% |
| Since start (yearly) | +22.3% | +11.2% |
Monthly SIP of ₹10,000
| Period | Invested | Value now | Yearly return |
|---|---|---|---|
| 1 year | ₹1,20,000 | ₹1,39,028 | +26.7% |
Other plan of this fund: WhiteOak Capital Pharma and Healthcare Fund - Regular Plan - Growth